Auszug
Lebensqualität (LQ)ist nach der Überlebenszeit das wichtigste Behandlungsziel für Krebspatienten. Dies gilt von der Diagnosestellung an für den gesamten Krankheits- und Behandlungsverlauf.Für Patienten mit nicht malignen bzw.nicht lebensbedrohlichen Erkrankungen sind Lebensqualität oder spezifische Aspekte davon primäre Therapieziele. Gesundheitsbezogene Lebensqualität ist heute mit naturwissenschaftlichen Methoden zuverlässig messbar.Es lassen sich so Auswirkungen von Krankheit und Therapie systematisch darstellen und vergleichen. Dies gilt insbesondere für die Uroonkologie,aber auch für das Gesamtgebiet “Urologie„.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aaronson NK, Ahmedzai S, Bergman B(1993) The European Organization for Research and Treatment of Cancer. QLQ C-30: A Quality of Life Instrument for use in International clinical Trials in Oncology. J Natl Cancer Inst 85: 365–376
Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland in Zusammenarbeit mit dem Robert Koch Institut (Hrsg Krebs in Deutschland-Häufigkeiten und Trends 4, überarbeitete, aktualisierte Ausgabe. Saarbrücken2004
Atzpodien J, Kuechler T, Wandert T, Reitz M(2003) Rapid deterioration in quality of life during interleukin-2-and a-interferon-based home therapy of renal cell carcinoma is associated with a good outcome. British Journal of Cancer:89,50–54
Bestmann B, Rohde V, Siebmann JU, Galalae R, Weidner W, Kuchler T(2006) Validation of the German prostate-specific module. World J Urol Jan 19: 17[Epubaheadofprint]
Biermann CW; Küchler T(1999) Lebensqualität in der urologischen Onkologie. Urologe[A] 38: 189–200
Biermann CW, Schmidt C, Kuechler T(1995) Development of a life quality questionnaire in bladder cancer surgery. BritishJournalofUrology 79: 411–413
Boeckmann W, Jakse G:Nierenzellkarzinom.In:Rübben H(Hrsg):Uro Onkologie,3.vollständigüberarbeiteteAuflage, Springer Verlag 2001
Bullinger M (1995) German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med 1995 Nov;41(10): 1359–1366
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon Jetal.(1993) TheFunctional Assessment of Cancer Therapyscale:development and validation of the general measure. J Clin Onco lMar;11(3): 570–579
Dahl AA, Mykletun A, Fossa SD(2005) Quality of life in survivor softes-ticular cancer. Urol Oncol May Jun;23(3): 193–200.Review
Davis JW, Kuban DA, Lynch DF, Schellhammer PF(2001) Quality of life after treatment for localized prostate cancer:differences based on treatment modality. J UrolSep;166(3): 947–952
Deutsche Krebsgesellschaft (1990):Konsensus-Konferenz: Erfassung von Lebensqualität in der Onkologie-Konzepte Methodik und Anwendung 3: 7–10
Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, Dhaese S, Zurlo A(2003) Beyond the development of health-related quality-of-life(HRQOL)measures:a check list for evaluating HRQOL out comes in cancer clinical trial sdoes HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol Sep 15;21(18): 3502–3511
Fegg MJ, Gerl A, Vollmer TC, Gruber U, Jost C, Meiler S, Hiddemann W(2003) Subjektive Quality of Life and sexual functioning after germ-cell tumour therapy. British Journal of Cancer 89(12): 2002–2006
Fleer J, Hoekstra HJ, Sleijfer DT,Hoekstra-Weebers JEHM: Quality of life of survivors of testicular germ cell cancer. Support Care Cancer(2004)12: 476–486
Fossa SD, deWit R, Roberts T, Wilkinson PT, deMulder PHM, Mead GM, Cook P, dePrijk L, Stenning S, Aaronson NK, Bottomley A, Colette L(2003) Quality of Life in Good Prognosis Patients with Metastatic Germ Cell Cancer: A Prospective Study of the European Organization fro Research and Treatment of Cancer Genitourinary Group/ Medical Research Cuncil Testicular Cancer Study Group (30941/ TE20). J Clin Oncol 21(6): 1107/1118
Fulmer BR, Bissonette EA, Petroni GR, Theodorescu D(2001) Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy. CancerJun1;91(11): 2046–55
Henrich G; Herschbach P(2000) Articles-Questions on Life Satisfaction (FLZM) A Short Questionnaire for Assessing Subjective Quality of Life European journal of psychological assessment, Bd.16,3: 150–159
Krupski T, Petroni GR, Bissonette EA, Theodorescu D(2000) Quality-oflife comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology May;55(5): 736–42
Küchler, Th., Schreiber, H.W(1989) “Lebensqualität in der Allgemeinchirurgie-Konzepte und praktische Möglichkeiten der Messung„,HÄB 43,246–250
Lebeau T, Perrotte P, Valiquette L, Benard F, McCormack M, Saad F, Karakiewicz PI (2005) Validation of prostate cancer index and SF-12 short forms Can J Urol Dec;12(6): 2873–9
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH(1998) The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care Jul;36(7): 1002–12
Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM(1999) Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology Sep;54(3): 503–8
McCammon KA, Kolm P, Main B, Schellhammer PF(1999) Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology Sep;54(3): 509–16
Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick MI, Smalley SR etal. (1995) Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association J Urol Dec;154(6): 2144–8
Preiß J, Dornoff W, Hagmann FG, Schmieder A (2004) Onkologie 2004/2005-Interdisziplinäre Empfehlungen zur Therapie. 12. Auflage, Zuckschwerdt, München Wien New York
Spilker B (ed) (1996) Quality of life and pharmacoeconomics in clinical trials.Lippincott-Raven Philadelphia
Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IK(1999) Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin Epidemiol Jul;52(7): 653–66
Tamburini M, Filiberti A, Barbieri A, Zanoni F, Pizzocaro G, Barletta L, Ventafridda V (1989) Psychological aspects of testis cancer therapy: a prospective study. J Urol 142: 1487–1489
Ware JEJr, Sherbourne CD(1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care Jun;30(6): 473–83
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Küchler, T., Bestmann, B. (2007). Lebensqualität in der Uroonkologie. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33848-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-33848-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33847-5
Online ISBN: 978-3-540-33848-2
eBook Packages: Medicine (German Language)